This case is designed to help you understand the dilemma of legality vs. ethicality and understand the role played by the government and quasi government agencies in addressing societal issues. In addition, it will provide you an opportunity to discuss how pharmaceutical companies struggle to maintain a balance between doing good for the investors and for their consumers and to discuss the role of fairness in pricing. QUESTIONS 1. As you read the case, what do you think of Shkreli's actions? 2. Which philosophy of corporate governance - shareholder capitalism or stakeholder capitalism - do you ascribe to? Which do you think is more suitable for a non-discretionary industry like pharmaceuticals? 3. What parameter should be followed by pharmaceutical companies when pricing products? Is the price hike for established drugs such as Daraprim justified? 4. What, according to you, is the role of the government in incentivizing pharmaceutical companies to undertake research and development for rare diseases? 5. What risks did Turing face? What should it do? 6. Who in a corporation is responsible for upholding ethical practices? You will be graded based on how completely and accurately you answer the questions. You must answer in complete sentences (no bullet points)